Determinants of Health-related Quality of Life for Patients After Renal Lithotripsy: PNL Versus RIRS
1 other identifier
observational
200
1 country
1
Brief Summary
Percutaneous nephrolithotomy (PNL) and Retrograde intrarenal surgery (RIRS) are well-established procedures for renal stone fragmentation; however, the morbidity, hospitalization, and lost work hours associated with these procedures can negatively affect the health-related quality of life (HRQoL) of the patients \[1-3\]. The choice of modality is based on the European Association of Urology (EAU) and/or American Urological Association (AUA) guidelines. However, selecting a modality is challenging, considering the advantages and drawbacks of both modalities. RIRS while minimally invasive, has an inferior stone-free rate compared with PNL; however, PNL requires general anesthesia and longer hospitalization \[4\]. The need to select the therapeutic modality for urinary lithotripsy based not only on the stone-free rate but also on the subsequent HRQoL of the patient is increasingly recognized \[5\]. The concept of HRQoL is multidimensional, which includes psychosocial, physical, and emotional factors, as well as patient autonomy, and is applicable to a wide variety of medical conditions \[6\]. Patients with urolithiasis represent an ideal group for the investigation of HRQoL, considering the disease's high prevalence, non-life-threatening nature, severe symptoms, and high recurrence rate \[3\]. However, only a few longitudinal studies have investigated HRQoL in patients undergoing lithotripsy for urinary calculi \[7\]. Several studies have evaluated HRQoL using the Short-Form 36-item survey (SF-36) \[3, 7-9\]. Hence, this study aims to compare longitudinal HRQoL between PNL and RIRS at four timepoints: before surgery (Bef), on the day of discharge (0 mo), and 1 month (1 mo) and 6 months (6 mo) after surgical intervention, and to further investigate the factors that may significantly affect the HRQoL of these patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedFirst Submitted
Initial submission to the registry
May 1, 2023
CompletedFirst Posted
Study publicly available on registry
May 9, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2023
CompletedMay 9, 2023
May 1, 2023
2.5 years
May 1, 2023
May 1, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Determinants of health-related quality of life for patients after renal lithotripsy: PCNL vs RIRS
estimate quality of life patients after PCNL and after RIRS
2 years
Study Arms (2)
PCNL
PCNL group applicants will answer SF-36 questionnaire
RIRS
RIRS group applicants will answer SF-36 questionnaire
Interventions
applicants will fill health related quality of life SF-36 Questionnaire after PCNL or RIRS
Eligibility Criteria
all patients presented to our clinics will performing PCNL or RIRS 100 patents in each group
You may qualify if:
- all patients performing PNL or RIRS for renal stones 2-4 cm
You may not qualify if:
- Patients refuse to participate in this study Unfit patients Renal Stones more than 4 cm Renal Stones less than 2 cm
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
South Valley University
Qina, Qena Governorate, 831115, Egypt
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Urology
Study Record Dates
First Submitted
May 1, 2023
First Posted
May 9, 2023
Study Start
January 1, 2021
Primary Completion
July 15, 2023
Study Completion
August 1, 2023
Last Updated
May 9, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share